Coronary Disease

SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study)

Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy

A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS)

Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II)

Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries

Conor Cobalt Chromium Reservoir Based Stent With Sirolimus Elution in Native Coronary Artery Lesions

Study of Otamixaban Versus Unfractionated Heparin (UFH) and Eptifibatide in Non-ST Elevation Acute Coronary Syndrome

Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass

Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries

The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention

A Randomized Phase 1 Dose-Escalation Study of Subcutaneously(SC) Administered RUC-4

Pharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild and Moderate Hepatic Impairment

Pharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild, Moderate and Severe Renal Impairment

Study of the Tolerability, Pharmacokinetics, and Pharmacodynamics of INS50589 Intravenous Infusion in Healthy Volunteers

Change History and Adopt a Robotic SolutioN for anGioplasty procedurE

Anatomic Versus Physiologic Guidance for Complete Revascularization With DES Eluting in Patients With CAD

Comparison Between Optimal Coherence Tomography Guidance and Angiography Guidance in Percutaneous Coronary Intervention

A Study to Obtain Additional Information on the Use of CorMatrix® CanGaroo ECM® Envelope

Obtain Additional Information on Use of CorMatrix ECM (Extracellular Matrix)

To Study the Safety and Clinical Outcomes of the Absorb Bioresorbable Vascular Scaffold (BVS) System in Patients With de Novo Lesions in Previously Untreated Vessels

Randomized Comparison of ExoSeal® and Angio-Seal Vascular Closure Devices: The CLOSE-UP II Trial

ABSORB Clinical Investigation, Cohort B

EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel Disease

ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical Investigation

DaVinci Registry(Distinctly Assess Vision in Coronary Intervention)